...
首页> 外文期刊>Bioorganic and Medicinal Chemistry >Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.
【24h】

Application of multicomponent reactions to antimalarial drug discovery. Part 2: New antiplasmodial and antitrypanosomal 4-aminoquinoline gamma- and delta-lactams via a 'catch and release' protocol.

机译:多组分反应在抗疟药发现中的应用。第2部分:通过“捕获和释放”方案,新的抗血浆和抗锥虫的4-氨基喹啉γ-和内酰胺。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A parallel synthesis of a new series of 4-aminoquinoline gamma- and delta-lactams synthesized via the Ugi 3-component 4-centre multicomponent reaction is described. The basicity of the quinoline nitrogen was exploited in the purification of compounds via a 'catch and release' protocol. Yields ranging from 60% to 77% and purities as high as 96% were obtained. Compound 29, the most active against a chloroquine-resistant W2 strain of Plasmodium falciparum with an IC(50) of 0.096 microM, also inhibited recombinant falcipain-2 in vitro (IC(50)= 17.6 microM). Compound 17 inhibited the growth of Trypanosoma brucei with an ED(50) of 1.44 microM whilst exhibiting a favourable therapeutic index of 409 against a human KB cell line.
机译:描述了通过Ugi 3组分4中心多组分反应合成的一系列新的4-氨基喹啉γ-和δ-内酰胺类的平行合成。喹啉氮的碱性被用于通过“捕获和释放”方案纯化化合物。获得了60%至77%的产率和高达96%的纯度。化合物29对恶性疟原虫的耐氯喹W2菌株最具活性,IC(50)为0.096 microM,在体外也抑制了重组falcipain-2(IC(50)= 17.6 microM)。化合物17以1.44 microM的ED(50)抑制布氏锥虫的生长,同时对人KB细胞系表现出409的有利治疗指数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号